U.S. FDA Grants Priority Review for Vascepa® (Icosapent Ethyl) Supplemental New Drug Application Seeking Cardiovascular Risk Reduction Indication

Stacey Gandler
Brand Nourishment

Bud Bilanich
Success Coach

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Matthew Durham
Omnidynamic Marketing

Joey Cohen
Medication Adherence

Suma Ramadas, PhD
Medical Affairs

Amy Giles
Increasing Engagement

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access

David Linetsky
Point-of-Care Marketing

Liz Kane
Impactful Strategy